artelo
biosciences
present
wainwright
annual
global
investment
conference
september
la
jolla
globe
newswire
artelo
biosciences
nasdaq
artl
clinical
stage
biopharmaceutical
company
developing
therapeutics
modulate
endocannabinoid
system
today
announced
presenting
wainwright
annual
global
investment
conference
held
virtually
september
gregory
gorgas
president
chief
executive
officer
artelo
biosciences
scheduled
present
tuesday
september
eastern
time
presentation
webcast
live
conference
event
platform
accessed
artelo
biosciences
artelo
biosciences
san
biopharmaceutical
company
dedicated
development
commercialization
proprietary
therapeutics
targeting
endocannabinoid
system
related
pathways
artelo
rapidly
advancing
portfolio
broadly
applicable
product
candidates
designed
address
significant
unmet
needs
multiple
diseases
conditions
including
anorexia
cancer
pain
inflammation
led
proven
biopharmaceutical
executives
collaborating
highly
respected
researchers
technology
experts
company
applies
leading
edge
scientific
regulatory
commercial
discipline
develop
therapies
information
available
twitter
artelobio
